Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Antibodies Licensed for Multi-Target Immunotherapies

MedImmune, the biologics subsidiary of drug maker AstraZeneca, is licensing antibodies from a biotechnology company for treatments that simultaneously address two or more cancer targets. . . . → Read More: Antibodies Licensed for Multi-Target Immunotherapies

High False-Positive Rate Found in Consumer Genetic Tests

Follow-up reviews of results from direct-to-consumer genetic tests show 40 percent of the actionable gene variations reported in the tests, including some indicating disease risk, were erroneous. . . . → Read More: High False-Positive Rate Found in Consumer Genetic Tests

Immune Disease Precision Therapy Company Starts Up

An enterprise to discover biomarkers and precise treatments for individuals with immune system disorders is starting up, founded by six researchers in the U.S. and Europe. . . . → Read More: Immune Disease Precision Therapy Company Starts Up

Novartis Licenses Biomaterial for Cancer Immunotherapy

Drug maker Novartis is licensing from a lab at Harvard University a biocompatible material designed to provide delivery of treatments that invoke the immune system to fight cancer. . . . → Read More: Novartis Licenses Biomaterial for Cancer Immunotherapy

More Accurate Thyroid Cancer Screening Technology Advances

A European initiative is developing a laser-enhanced technology to better distinguish between cancerous and benign thyroid nodules, for catching thyroid cancer earlier as well as preventing unnecessary surgeries. . . . → Read More: More Accurate Thyroid Cancer Screening Technology Advances

Cancer Drug Seen to Reverse Autism Spectrum Symptoms

Small doses of a drug for blood-related cancers are shown in lab mice to reverse social symptoms often found in children with autism spectrum disorder, a condition characterized by limited social activity. . . . → Read More: Cancer Drug Seen to Reverse Autism Spectrum Symptoms

Boron Radiation Therapy Company Forms with $40M Funding

A start-up enterprise, spun off from a fusion energy company, plans to develop radiation therapies for solid tumor cancers often considered difficult to treat with conventional methods. . . . → Read More: Boron Radiation Therapy Company Forms with $40M Funding

A.I. Shown to Boost Cancer Clinical Trial Enrollment

Early results from a system using a supercomputer and artificial intelligence to match breast cancer patients to clinical trials shows faster screening and higher enrollment rates in these studies compared to manual methods. . . . → Read More: A.I. Shown to Boost Cancer Clinical Trial Enrollment

Peptide Hydrogel Boosts Cancer Immunotherapies

A team at Rice University in Houston developed an injectable gel material that in lab mice slows the release of cancer immunotherapy drugs, enhancing the treatments’ effectiveness and reducing the need for repeated doses. . . . → Read More: Peptide Hydrogel Boosts Cancer Immunotherapies

Company Formed to Develop Cancer Cell Therapies

The MD Anderson Cancer Center in Houston is starting Optera Therapeutics Corp., a new company to commercialize its research on treating cancer with a patients’ own immune system cells. . . . → Read More: Company Formed to Develop Cancer Cell Therapies